AZD4017 / AstraZeneca 
Welcome,         Profile    Billing    Logout  
 8 Diseases   1 Trial   1 Trial   15 News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD4017 / AstraZeneca
2016-003060-40: Treating side effects of steroid medication

Ongoing
2
32
Europe
AZD4017, AZD4017, Tablet
University of Oxford, Clinical Trials and Research Governance, Medical Research Council, AstraZeneca
Adverse effects of prescribed glucocorticoid therapy, Side effects of prescribed steroids, Body processes [G] - Metabolic Phenomena [G03]
 
 
2017-001351-31: A study to assess the safety, rationale and effect of a new treatment to improve skin function and wound healing in patients with type 2 diabetes

Not yet recruiting
2
30
Europe
AZD4017, Tablet
University of Leeds, MRC Confidence in Concept Scheme
Type 2 diabetes, Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 

Download Options